Machine learning in drug delivery

For decades, drug delivery scientists have been performing trial-and-error experimentation to manually sample parameter spaces and optimize release profiles through rational design. To enable this approach, scientists spend much of their career learning nuanced drug-material interactions that drive...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of controlled release 2024-09, Vol.373, p.23-30
1. Verfasser: Gormley, Adam J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 30
container_issue
container_start_page 23
container_title Journal of controlled release
container_volume 373
creator Gormley, Adam J.
description For decades, drug delivery scientists have been performing trial-and-error experimentation to manually sample parameter spaces and optimize release profiles through rational design. To enable this approach, scientists spend much of their career learning nuanced drug-material interactions that drive system behavior. In relatively simple systems, rational design criteria allow us to fine tune release profiles and enable efficacious therapies. However, as materials and drugs become increasingly sophisticated and their interactions have non-linear and compounding effects, the field is suffering the Curse of Dimensionality which prevents us from comprehending complex structure-function relationships. In the past, we have embraced this complexity by implementing high-throughput screens to increase the probability of finding ideal compositions. However, this brute force method was inefficient and led many to abandon these fishing expeditions. Fortunately, methods in data science including artificial intelligence / machine learning (AI/ML) are providing ideal analytical tools to model this complex data and ascertain quantitative structure-function relationships. In this Oration, I speak to the potential value of data science in drug delivery with particular focus on polymeric delivery systems. Here, I do not suggest that AI/ML will simply replace mechanistic understanding of complex systems. Rather, I propose that AI/ML should be yet another useful tool in the lab to navigate complex parameter spaces. The recent hype around AI/ML is breathtaking and potentially over inflated, but the value of these methods is poised to revolutionize how we perform science. Therefore, I encourage readers to consider adopting these skills and applying data science methods to their own problems. If done successfully, I believe we will all realize a paradigm shift in our approach to drug delivery. [Display omitted] •Complex drug-material interactions challenge the design of drug delivery systems.•Machine learning is useful for navigating large parameter spaces and structure-function modeling.•When coupled with automation, the drug delivery community may see significant gains in productivity.
doi_str_mv 10.1016/j.jconrel.2024.06.045
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11384327</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168365924004024</els_id><sourcerecordid>3071514163</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-2f2c3fe25ed13151fa1ea349e731dfacd407c5b0c434894da18a2c82be5eb88b3</originalsourceid><addsrcrecordid>eNqFkM1OwzAQhC0EoqXwCKBw45Jgx3binBCq-JOKuMDZcuxN6yh1ip1U6tuTqqXAidMedmZ29kPokuCEYJLd1kmtW-ehSVKcsgRnCWb8CI2JyGnMioIfo_GgEzHNeDFCZyHUGGNOWX6KRlQUuMgxG6PrV6UX1kHUgPLOunlkXWR8P48MNHYNfnOOTirVBLjYzwn6eHx4nz7Hs7enl-n9LNaMZF2cVqmmFaQcDKGEk0oRUJQVkFNiKqUNw7nmJdaMMlEwo4hQqRZpCRxKIUo6QXe73FVfLsFocJ1XjVx5u1R-I1tl5d-Nsws5b9eSECoYTfMh4Waf4NvPHkInlzZoaBrloO2DpDgfig1t6SDlO6n2bQgeqsMdguWWr6zlnq_c8pU4kwPfwXf1u-TB9Q305wsYUK0teBm0BafBWA-6k6a1_5z4AvmMjxM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3071514163</pqid></control><display><type>article</type><title>Machine learning in drug delivery</title><source>Elsevier ScienceDirect Journals</source><creator>Gormley, Adam J.</creator><creatorcontrib>Gormley, Adam J.</creatorcontrib><description>For decades, drug delivery scientists have been performing trial-and-error experimentation to manually sample parameter spaces and optimize release profiles through rational design. To enable this approach, scientists spend much of their career learning nuanced drug-material interactions that drive system behavior. In relatively simple systems, rational design criteria allow us to fine tune release profiles and enable efficacious therapies. However, as materials and drugs become increasingly sophisticated and their interactions have non-linear and compounding effects, the field is suffering the Curse of Dimensionality which prevents us from comprehending complex structure-function relationships. In the past, we have embraced this complexity by implementing high-throughput screens to increase the probability of finding ideal compositions. However, this brute force method was inefficient and led many to abandon these fishing expeditions. Fortunately, methods in data science including artificial intelligence / machine learning (AI/ML) are providing ideal analytical tools to model this complex data and ascertain quantitative structure-function relationships. In this Oration, I speak to the potential value of data science in drug delivery with particular focus on polymeric delivery systems. Here, I do not suggest that AI/ML will simply replace mechanistic understanding of complex systems. Rather, I propose that AI/ML should be yet another useful tool in the lab to navigate complex parameter spaces. The recent hype around AI/ML is breathtaking and potentially over inflated, but the value of these methods is poised to revolutionize how we perform science. Therefore, I encourage readers to consider adopting these skills and applying data science methods to their own problems. If done successfully, I believe we will all realize a paradigm shift in our approach to drug delivery. [Display omitted] •Complex drug-material interactions challenge the design of drug delivery systems.•Machine learning is useful for navigating large parameter spaces and structure-function modeling.•When coupled with automation, the drug delivery community may see significant gains in productivity.</description><identifier>ISSN: 0168-3659</identifier><identifier>ISSN: 1873-4995</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/j.jconrel.2024.06.045</identifier><identifier>PMID: 38909704</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Artificial intelligence ; Controlled release ; Drug delivery ; Encapsulation ; Formulation ; Machine learning</subject><ispartof>Journal of controlled release, 2024-09, Vol.373, p.23-30</ispartof><rights>2024 The Author(s)</rights><rights>Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c416t-2f2c3fe25ed13151fa1ea349e731dfacd407c5b0c434894da18a2c82be5eb88b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0168365924004024$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38909704$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gormley, Adam J.</creatorcontrib><title>Machine learning in drug delivery</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>For decades, drug delivery scientists have been performing trial-and-error experimentation to manually sample parameter spaces and optimize release profiles through rational design. To enable this approach, scientists spend much of their career learning nuanced drug-material interactions that drive system behavior. In relatively simple systems, rational design criteria allow us to fine tune release profiles and enable efficacious therapies. However, as materials and drugs become increasingly sophisticated and their interactions have non-linear and compounding effects, the field is suffering the Curse of Dimensionality which prevents us from comprehending complex structure-function relationships. In the past, we have embraced this complexity by implementing high-throughput screens to increase the probability of finding ideal compositions. However, this brute force method was inefficient and led many to abandon these fishing expeditions. Fortunately, methods in data science including artificial intelligence / machine learning (AI/ML) are providing ideal analytical tools to model this complex data and ascertain quantitative structure-function relationships. In this Oration, I speak to the potential value of data science in drug delivery with particular focus on polymeric delivery systems. Here, I do not suggest that AI/ML will simply replace mechanistic understanding of complex systems. Rather, I propose that AI/ML should be yet another useful tool in the lab to navigate complex parameter spaces. The recent hype around AI/ML is breathtaking and potentially over inflated, but the value of these methods is poised to revolutionize how we perform science. Therefore, I encourage readers to consider adopting these skills and applying data science methods to their own problems. If done successfully, I believe we will all realize a paradigm shift in our approach to drug delivery. [Display omitted] •Complex drug-material interactions challenge the design of drug delivery systems.•Machine learning is useful for navigating large parameter spaces and structure-function modeling.•When coupled with automation, the drug delivery community may see significant gains in productivity.</description><subject>Artificial intelligence</subject><subject>Controlled release</subject><subject>Drug delivery</subject><subject>Encapsulation</subject><subject>Formulation</subject><subject>Machine learning</subject><issn>0168-3659</issn><issn>1873-4995</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFkM1OwzAQhC0EoqXwCKBw45Jgx3binBCq-JOKuMDZcuxN6yh1ip1U6tuTqqXAidMedmZ29kPokuCEYJLd1kmtW-ehSVKcsgRnCWb8CI2JyGnMioIfo_GgEzHNeDFCZyHUGGNOWX6KRlQUuMgxG6PrV6UX1kHUgPLOunlkXWR8P48MNHYNfnOOTirVBLjYzwn6eHx4nz7Hs7enl-n9LNaMZF2cVqmmFaQcDKGEk0oRUJQVkFNiKqUNw7nmJdaMMlEwo4hQqRZpCRxKIUo6QXe73FVfLsFocJ1XjVx5u1R-I1tl5d-Nsws5b9eSECoYTfMh4Waf4NvPHkInlzZoaBrloO2DpDgfig1t6SDlO6n2bQgeqsMdguWWr6zlnq_c8pU4kwPfwXf1u-TB9Q305wsYUK0teBm0BafBWA-6k6a1_5z4AvmMjxM</recordid><startdate>20240901</startdate><enddate>20240901</enddate><creator>Gormley, Adam J.</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240901</creationdate><title>Machine learning in drug delivery</title><author>Gormley, Adam J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-2f2c3fe25ed13151fa1ea349e731dfacd407c5b0c434894da18a2c82be5eb88b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Artificial intelligence</topic><topic>Controlled release</topic><topic>Drug delivery</topic><topic>Encapsulation</topic><topic>Formulation</topic><topic>Machine learning</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gormley, Adam J.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gormley, Adam J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Machine learning in drug delivery</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2024-09-01</date><risdate>2024</risdate><volume>373</volume><spage>23</spage><epage>30</epage><pages>23-30</pages><issn>0168-3659</issn><issn>1873-4995</issn><eissn>1873-4995</eissn><abstract>For decades, drug delivery scientists have been performing trial-and-error experimentation to manually sample parameter spaces and optimize release profiles through rational design. To enable this approach, scientists spend much of their career learning nuanced drug-material interactions that drive system behavior. In relatively simple systems, rational design criteria allow us to fine tune release profiles and enable efficacious therapies. However, as materials and drugs become increasingly sophisticated and their interactions have non-linear and compounding effects, the field is suffering the Curse of Dimensionality which prevents us from comprehending complex structure-function relationships. In the past, we have embraced this complexity by implementing high-throughput screens to increase the probability of finding ideal compositions. However, this brute force method was inefficient and led many to abandon these fishing expeditions. Fortunately, methods in data science including artificial intelligence / machine learning (AI/ML) are providing ideal analytical tools to model this complex data and ascertain quantitative structure-function relationships. In this Oration, I speak to the potential value of data science in drug delivery with particular focus on polymeric delivery systems. Here, I do not suggest that AI/ML will simply replace mechanistic understanding of complex systems. Rather, I propose that AI/ML should be yet another useful tool in the lab to navigate complex parameter spaces. The recent hype around AI/ML is breathtaking and potentially over inflated, but the value of these methods is poised to revolutionize how we perform science. Therefore, I encourage readers to consider adopting these skills and applying data science methods to their own problems. If done successfully, I believe we will all realize a paradigm shift in our approach to drug delivery. [Display omitted] •Complex drug-material interactions challenge the design of drug delivery systems.•Machine learning is useful for navigating large parameter spaces and structure-function modeling.•When coupled with automation, the drug delivery community may see significant gains in productivity.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>38909704</pmid><doi>10.1016/j.jconrel.2024.06.045</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0168-3659
ispartof Journal of controlled release, 2024-09, Vol.373, p.23-30
issn 0168-3659
1873-4995
1873-4995
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11384327
source Elsevier ScienceDirect Journals
subjects Artificial intelligence
Controlled release
Drug delivery
Encapsulation
Formulation
Machine learning
title Machine learning in drug delivery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T04%3A05%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Machine%20learning%20in%20drug%20delivery&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Gormley,%20Adam%20J.&rft.date=2024-09-01&rft.volume=373&rft.spage=23&rft.epage=30&rft.pages=23-30&rft.issn=0168-3659&rft.eissn=1873-4995&rft_id=info:doi/10.1016/j.jconrel.2024.06.045&rft_dat=%3Cproquest_pubme%3E3071514163%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3071514163&rft_id=info:pmid/38909704&rft_els_id=S0168365924004024&rfr_iscdi=true